Researchers found that IDH1 k224 acetylation tightly controls enzymatic activity through the HIF1a-SRC axis and promotes the liver metastasis of CRC and that SIRT2 can be a potential strategy for preventing CRC liver metastasis because of its role in inhibiting the acetylation and enzymatic activity of IDH[59]. Here, IDH1 is linked to colorectal carcinoma.